Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Iselin, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Outlook Therapeutics, Inc. has filed 815 SEC EDGAR filings since 10 Aug 2015

SEC filing history

Showing 376-400 of 815 matching filings.

Per page
25
Current page
16
D File 021-389278

D filing

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Feb 2021
Reporting date
10 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
11 Feb 2021
Reporting date
09 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37759

PRE 14A

Filing date
10 Feb 2021
Reporting date
24 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89495

SC 13D/A

Filing date
05 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89495

AMENDMENT NO. 13

Filing date
02 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
02 Feb 2021
Reporting date
28 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-231922

424B5

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-231922

FWP

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-231922

FREE WRITING PROSPECTUS

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-231922

424B5

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-37759

10-K/A

Filing date
28 Jan 2021
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89495

SABBY 13G-A OTLK 1.05.21

Filing date
05 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
28 Dec 2020
Reporting date
23 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
06 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
09 Oct 2020
Reporting date
08 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2020
Reporting date
05 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Oct 2020
Reporting date
05 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .